Choose ALUNBRIG® (brigatinib): Download Helpful Resources for Patients
Dosing Guide
Patient Brochure
Current Topics in ALK+ mNSCLC
Access Guide
Video Resources
Talking ALK-Positive Opinions
Dr. Viola W. Zhu provides her perspective on treating patients with ALK+ mNSCLC in the front line and reviews the first-line clinical data for ALUNBRIG.
Exploring Key Efficacy, Safety, and Patient Data
Dr. Alex Spira, Director of the Virginia Cancer Specialists Research Institute, discusses ALUNBRIG for the treatment of adult patients with ALK+ mNSCLC.
Connect with our team
Learn more about ALUNBRIG for first-line patients with ALK+ mNSCLC from an ALUNBRIG representative.
ALUNBRIG SMART Program
Discover whether ALUNBRIG is right for your patient with a 1-month free trial